Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2012

Aug 8, 2012

30071_dirs_2012-08-08_f8a3c831-fa1a-4f07-8a5c-e590c14e4720.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2012-08-06

Reporting Person: WAREHAM JOHN P (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-08-06 ResMed Common Stock M 12000 $23.095 Acquired 22000 Direct
2012-08-06 ResMed Common Stock S 12000 $35.7354 Disposed 10000 Direct
2012-08-07 ResMed Common Stock M 5942 $21.025 Acquired 15942 Direct
2012-08-07 ResMed Common Stock S 5942 $35.80 Disposed 10000 Direct
2012-08-07 ResMed Common Stock M 9058 $21.025 Acquired 19058 Direct
2012-08-07 ResMed Common Stock S 9058 $36.12 Disposed 10000 Direct
2012-08-07 ResMed Common Stock M 3000 $21.025 Acquired 13000 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2012-08-06 ResMed NQ Stock Options $23.095 M 12000 Disposed 2013-11-10 ResMed Common Stock (12000) Direct
2012-08-07 ResMed NQ Stock Options $21.025 M 5942 Disposed 2014-11-07 ResMed Common Stock (5942) Direct
2012-08-07 ResMed NQ Stock Options $21.025 M 9058 Disposed 2014-11-07 ResMed Common Stock (9058) Direct
2012-08-07 ResMed NQ Stock Options $21.025 M 3000 Disposed 2014-11-07 ResMed Common Stock (3000) Direct

Footnotes

F1: Represents date options first became exercisable.